Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis

Life Sciences

Volumn 75, Issue 13, 2004, Pages 1579-1594

  Cheng, Yeung Leung ^a,b   Chang, Wen Liang ^a   Lee, Shih Chun ^b   Liu, Yau Gye ^b   Chen, Cheng Jueng ^b   Lin, Shinn Zong ^c   Tsai, Nu Man ^c   Yu, Dah Shyong ^b   Yen, Chung Yang ^b   Harn, Horng Jyh ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Angelica sinensis; Apoptosis; Bcl 2; Cancer; Caspases; Cell cycle

Indexed keywords

ACETONE; ANGELICA SINENSIS EXTRACT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; DNA; HOE 33342; LIPOCORTIN 5; PROTEIN BCL 2;

ANGELICA SINENSIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN HT29; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVATION; GYNECOLOGIC DISEASE; HUMAN; HUMAN CELL; IC 50; PRESCRIPTION; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING;

ACETONE; AMINO ACID CHLOROMETHYL KETONES; ANGELICA; ANNEXIN A5; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CASPASES; CELL CYCLE; CHROMATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; LETHAL DOSE 50; TIME FACTORS; TUMOR CELLS, CULTURED;

ANGELICA SINENSIS;

EID: 3142655814     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.03.009     Document Type: Article

References (42)

1. Baell J.B., Huang D.C. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochemical Pharmacology. 64(5-6):2002;851-863
2. Bonham M., Arnold H., Montgomery B., Nelson P.S. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. Cancer Research. 62(14):2002;3920-3924
3. Clarke R.G., Lund E.K., Johnson I.T., Pinder A.C. Apoptosis can be detected in attached colonic adenocarcinoma HT29 cells using annexin V binding, but not by TUNEL assay or sub-G0 DNA content. Cytometry. 39(2):2002;141-150
4. Cole S.P. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemotherapy and Pharmacology. 17(3):1986;259-263
5. de Bernard M., Moschioni M., Papini E., Telford J.L., Rappuoli R., Montecucco C. TPA and butyrate increase cell sensitivity to the vacuolating toxin of Helicobacter pylori. FEBS Letters. 436(2):1998;218-222
6. Diaz-Ruiz C., Montaner B., Perez-Tomas R. Prodigiosin induces cell death and morphological changes indicative of apoptosis in gastric cancer cell line HGT-1. Histology and Histopathology. 16(2):2001;415-421
7. Dixon S.C., Soriano B.J., Lush R.M., Borner M.M., Figg W.D. Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Annals of Pharmacotherapy. 31(1):1997;76-82
8. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 411(6835):2001;342-348
9. Goodsell D.S. The molecular perspective: Bcl-2 and apoptosis. Stem Cells. 20(4):2002;355-356
10. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100(1):2000;57-70
11. Henics T., Wheatley D.N. Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biology of the Cell. 91(7):1999;485-498
12. Hosono S., Lee C.S., Chou M.J., Yang C.S., Shih C.H. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene. 6(2):1991;237-243
13. Hu H., Ahn N.S., Yang X., Lee Y.S., Kang K.S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. International Journal of Cancer. 102(3):2002;250-253
14. Hunter T., Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 79(4):1994;573-582
15. Hyun P.W., Hee C.Y., Won J.C., Oh P.J., Kim K., Hyuck I.Y., Lee M.H., Ki K.W., Park K. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochemical and Biophysical Research Communications. 300(1):2003;230-235
16. Johnson V.L., Ko S.C., Holmstrom T.H., Eriksson J.E., Chow S.C. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. Journal of Cell Science. 113(Pt 17):2000;2941-2953
17. Kao S.T., Yeh C.C., Hsieh C.C., Yang M.D., Lee M.R., Liu H.S., Lin J.G. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sciences. 69(13):2001;1485-1496
18. Kerr J.F., Gobe G.C., Winterford C.M., Harmon B.V. Anatomical methods in cell death. Methods in Cell Biology. 46:1995;1-27
19. Kim S.H., Lee S.E., Oh H., Kim S.R., Yee S.T., Yu Y.B., Byun M.W., Jo S.K. The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine. American Journal of Chinese Medicines. 30(1):2002;127-137
20. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275(5303):1997;1132-1136
21. Lee S.M., Li M.L., Tse Y.C., Leung S.C., Lee M.M., Tsui S.K., Fung K.P., Lee C.Y., Waye M.M. Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sciences. 71(19):2002;2267-2277
22. Li X.K., Motwani M., Tong W., Bornmann W., Schwartz G.K. Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Molecular Pharmacology. 58(6):2000;1287-1293
23. Lowe E.D., Tews I., Cheng K.Y., Brown N.R., Gul S., Noble M.E., Gamblin S.J., Johnson L.N. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry. 41(52):2002;15625-15634
24. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. Journal of Experimental Medicine. 182(5):1995;1545-1556
25. Park W.H., Kim E.S., Jung C.W., Kim B.K., Lee Y.Y. Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis. International Journal of Oncology. 22(2):2003;377-382
26. Schulte-Hermann R., Grasl-Kraupp B., Bursch W. Tumor development and apoptosis. International Archives of Allergy and Immunology. 105(4):1994;363-367
27. Schwartsmann G., Ratain M.J., Cragg G.M., Wong J.E., Saijo N., Parkinson D.R., Fujiwara Y., Pazdur R., Newman D.J., Dagher R., Di Leone L. Anticancer drug discovery and development throughout the world. Journal of Clinical Oncology. 20(18):2002;47S-59S
28. Uphoff C.C. Detection of mycoplasma contaminations in cell cultures by PCR analysis. Human Cell. 12(4):1999;229-236
29. van Engeland M., Ramaekers F.C., Schutte B., Reutelingsperger C.P. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 24(2):1996;131-139
30. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 31(1):1998;1-9
31. Vartanian A.A., Suzuki H., Poletaev A.I. The involvement of diadenosine 5′, 5″′-P1, P4-tetraphosphate in cell cycle arrest and regulation of apoptosis. Biochemical Pharmacology. 65(2):2003;227-235
32. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Investigation. 20(7-8):2002;1069-1079
33. Wang X., Wei L., Ouyang J.P., Muller S., Gentils M., Cauchois G., Stoltz J.F. Effects of an angelica extract on human erythrocyte aggregation, deformation and osmotic fragility. Clinical Hemorheology and Microcirculation. 24(3):2001;201-205
34. Xie F., Li X., Sun K., Chu Y., Cao H., Chen N., Wang W., Liu M., Liu W., Mao D. An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage. Journal of Traditional Chinese Medicines. 21(3):2001;225-231
35. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., Kojiro M. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Research. 54(2):1994;448-454
36. Ye Y.N., So H.L., Liu E.S., Shin V.Y., Cho C.H. Effect of polysaccharides from Angelica sinensis on gastric ulcer healing. Life Sciences. 72(8):2003;925-932
37. Ye Y.N., Koo M.W., Li Y., Matsui H., Cho C.H. Angelica sinensis modulates migration and proliferation of gastric epithelial cells. Life Sciences. 68(8):2001;961-968
38. Ye Y.N., Liu E.S., Li Y., So H.L., Cho C.C., Sheng H.P., Lee S.S., Cho C.H. Protective effect of polysaccharides-enriched fraction from Angelica sinensis on hepatic injury. Life Sciences. 69(6):2001;637-646
39. Ye Y.N., Liu E.S., Shin V.Y., Koo M.W., Li Y., Wei E.Q., Matsui H., Cho C.H. A mechanistic study of proliferation induced by Angelica sinensis in a normal gastric epithelial cell line. Biochemical Pharmacology. 61(11):2001;1439-1448
40. Yim T.K., Wu W.K., Pak W.F., Mak D.H., Liang S.M., Ko K.M. Myocardial protection against ischaemia-reperfusion injury by a Polygonum multiflorum extract supplemented 'Dang-Gui decoction for enriching blood', a compound formulation, ex vivo. Phytotherapy Research. 14(3):2000;195-199
41. Yu D.S., Ma C.P., Chang S.Y. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance. Urologic Research. 28(2):2000;86-92
42. Zhivotovsky B., Orrenius S., Brustugun O.T., Doskeland S.O. Injected cytochrome c induces apoptosis. Nature. 391(6666):1998;449-450